| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2025―Mar―14 |
Subcutaneous Administration of an Endocrine-Mimetic, Slow-Release Protein Material Reduces the Severity of SARS-CoV-2 Infection |
Eloi Parladé, Ferran Tarrés-Freixas, Marianna T.P. Favaro, Jara Lascorz, Merce Márquez-Matínez, Rosa Mendoza, José Luís Corchero, Guillermo Cantero, Núria Roca, Mónica Pérez, Neus Ferrer-Miralles, Esther Vazquez, Joaquim Segalés, Júlia Vergara-Alert, Antoni Villaverde |
| 2 |
[GO] |
2025―Feb―22 |
Navigating COVID-19: advancements in therapeutics and viral filtration technologies for Today's challenges and tomorrow's solutions |
Devesh Kapoor, Bhavna Kumar, Manmohan Singhal, Faiza Himasa Idris, Sonam M. Gandhi, Sankha Bhattachrya, Bhupendra G. Prajapati, Rahul Maheshwari |
| 3 |
[GO] |
2025―Feb―05 |
Investigation of Moxifloxacin-loaded terpenes enriched cationic cerosomes (TECs) as an adjunct pulmonary therapy for COVID-19: in-silico study; D-optimal optimization; aerodynamic simulation assessment and cytotoxic evaluation. |
Rofida Albash, Carol Yousry, Mahmoud A. El Hassab, Wagdy M. Eldehna, Ahmed Adel Alaa-Eldin |
| 4 |
[GO] |
2024―Sep―14 |
Novel inhalable nano-based/microparticles for enhanced sustained pulmonary delivery of remdesivir - a patient malleable treatment for coronaviruses infection: in vitro aerosolization, cytotoxicity assays and antiviral activity studies. |
Shahinaze A. Fouad, Fady A. Malaak, Mahmoud H. Teaima, Samia Omar, Omnia Kutkat, Sammar Fathy Elhabal, Mohamed El-Nabarawi |
| 5 |
[GO] |
2024―Sep―13 |
Proanthocyanidins-based adjuvant for enhanced immune responses of SARS-CoV-2 subunit vaccine |
Yun Sun, Zibo Han, Lifang Du, Xinming Zhang, Yuan Li, Zehua Lei, Fang Tang, Yu Liang, Yuanyuan Li, Jing Zhang, Jin Ren |
| 6 |
[GO] |
2024―May―20 |
Antiviral potential of rosuvastatin and hesperidin in combination with favipiravir liposomal nanoformulations in targeting the main protease (Mpro) of SARS-CoV-2: Molecular docking, molecular dynamics and in-vitro studies |
Hanan Elimam, Hossam S. El-Sawy, Marwa A.A. Fayed, Sara H. Mahmoud, Riham O. Bakr, Rasha M. Saleh, Ahmed Mostafa, Mohamed F. Elshal |
| 7 |
[GO] |
2024―Mar―13 |
Silk fibroin-based hydrogel as injectable carrier for prolonged immunization of plant-based COVID-19 subunit vaccine |
Nopparuj Soomherun, Ruttanaporn Kriangsaksri, Wanlapa Tanticharakunsiri, Ngamlak Foongsawat, Waranyoo Phoolcharoen, Supannikar Tawinwung, Saran Keeratihattayakorn, Juthamas Ratanavaraporn |
| 8 |
[GO] |
2023―Jun―08 |
Antimicrobial and anti-viral effects of selenium nanoparticles and selenoprotein based strategies: COVID-19 and beyond |
Amit Khurana, Prince Allawadhi, Vishakha Singh, Isha Khurana, Poonam Yadav, Kshirod Bihari Sathua, Sachin Allwadhi, Anil Kumar Banothu, Umashanker Navik, Kala Kumar Bharani |
| 9 |
[GO] |
2023―May―22 |
Corrigendum to “Quercitrin loaded cyclodextrin based nanosponge as a promising approach for management of lung cancer and COVID-19” [J. Drug Deliv. Sci. Technol. 77 (2022) 103921] |
Sally Abou Taleb, Yassmin Moatasim, Mohamed GabAllah, Marwa Hasanein Asfour |
| 10 |
[GO] |
2023―May―15 |
Nano-based techniques: A revolutionary approach to prevent covid-19 and enhancing human awareness |
Asaikkutti Annamalai, Vimala Karuppaiya, Dhineshkumar Ezhumalai, Praseeja Cheruparambath, Kaviarasu Balakrishnan, Arul Venkatesan |
| 11 |
[GO] |
2023―Apr―20 |
Inhalation phage therapy as a new approach to preventing secondary bacterial pneumonia in patients with moderate to severe COVID-19: A double-blind clinical trial study |
Hamid Reza Samaee, Gohar Eslami, Golnar Rahimzadeh, Majid Saeedi, Alireza Davoudi Badabi, Kofi Asare-Addo, Ali Nokhodchi, Fatemeh Roozbeh, Mahmood Moosazadeh, Roya Ghasemian, Ahmad Alikhani, Mohammad Sadegh Rezai |
| 12 |
[GO] |
2022―Dec―13 |
Development of favipiravir loaded PLGA nanoparticles entrapped in in-situ gel for treatment of Covid-19 via nasal route |
Vaishnavi Gattani, Shilpa Dawre |
| 13 |
[GO] |
2022―Oct―28 |
Quercitrin loaded cyclodextrin based nanosponge as a promising approach for management of lung cancer and COVID-19 |
Sally Abou Taleb, Yassmin Moatasim, Mohamed GabAllah, Marwa Hasanein Asfour |
| 14 |
[GO] |
2022―Sep―17 |
Oral inhalation of cannabidiol delivered from a metered dose inhaler to alleviate cytokine production induced by SARS-CoV-2 and pollutants |
Teerapol Srichana, Charisopon Chunhachaichana, Roongnapa S, Somchai Sawatdee, Narumon Changsan |
| 15 |
[GO] |
2022―Sep―08 |
Towards novel nano-based vaccine platforms for SARS-CoV-2 and its variants of concern: Advances, challenges and limitations |
Sally A. Helmy, Rasha M. El-Morsi, SohaA.M. Helmy, Soha M. El-Masry |
| 16 |
[GO] |
2022―Sep―06 |
Theranostic efficiency of biosurfactants against COVID-19 and similar viruses - A review |
Manoj Kumar Sarangi, Sasmita Padhi, L.D. Patel, Goutam Rath, Sitansu Sekhar Nanda, Dong Kee Yi |
| 17 |
[GO] |
2022―Jun―28 |
Lipid nanoparticles in the development of mRNA vaccines for COVID-19 |
Barnabas Wilson, Kannoth Mukundan Geetha |
| 18 |
[GO] |
2021―Nov―06 |
Emerging importance of nanotechnology-based approaches to control the COVID-19 pandemic; focus on nanomedicine iterance in diagnosis and treatment of COVID-19 patients |
Behnam Hashemi, Akram Firouzi-amandi, Halimeh Amirazad, Mehdi Dadashpour, Milad Shirvaliloo, Davood Nasrabadi, Majid Ahmadi, Roghayeh Sheervalilou, Mahdieh Ameri Shah Reza, Farhood Ghazi, Leila Roshangar |
| 19 |
[GO] |
2021―Oct―05 |
The quest for a better fight: How can nanomaterials address the current therapeutic and diagnostic obstacles in the fight against COVID-19? |
Sheyda Ranjbar, Yousef Fatahi, Fatemeh Atyabi |
| 20 |
[GO] |
2021―Sep―15 |
Delineating a potent antiviral activity of Cuphea ignea extract loaded nano-formulation against SARS-CoV-2: In silico and in vitro studies |
Dina B. Mahmoud, Walaa M. Ismail, Yassmin Moatasim, Omnia Kutkat, Aliaa N. ElMeshad, Shahira M. Ezzat, Kadriya S. El Deeb, Ahlam M. El-Fishawy, Mokhtar R. Gomaa, Ahmed Kandeil, Ahmed A. Al-karmalawy, Mohamed A. Ali, Ahmed Mostafa |
| 21 |
[GO] |
2021―Jun―10 |
Nanotherapeutics for treating coronavirus diseases |
Thennakoon M. Sampath U. Gunathilake, Yern Chee Ching, Hiroshi Uyama, Cheng Hock Chuah |
| 22 |
[GO] |
2021―Feb―24 |
The pulmonary route as a way to drug repositioning in COVID-19 therapy |
Michelle Alvares Sarcinelli, Thalita Martins da Silva, Andressa Daniele Artico Silva, Beatriz Ferreira de Carvalho Patricio, Flávia Costa Mendes Paiva, Raissa Santos de Lima, Manuela Leal da Silva, Helvécio Vinícius Antunes Rocha |
| 23 |
[GO] |
2021―Feb―21 |
Recent updates in COVID-19 with emphasis on inhalation therapeutics: nanostructured and targeting systems |
Ahmed A.H. Abdellatif, Hesham M. Tawfeek, Ahmed Abdelfattah, Gaber El-Saber Batiha, Helal F. Hetta |
| 24 |
[GO] |
2020―Sep―28 |
Can human overcome viral hijack-? Comprehensive review on COVID-19 in the view of diagnosis and mitigation across countries |
Maheswari Nagendran, Juliana John, Kavithakani Annamalai, Muthu Iswarya Gandhi Sethuraman, Nirkayani Balamurugan, Harish Kumar Rajendran, Mohammed Askkar Deen Fakrudeen, Ragavan Chandrasekar, Shivendu Ranjan, Velayudhaperumal Chellam Padmanaban |
| 25 |
[GO] |
2020―Sep―02 |
Type of Article: REVIEW Pharmaceutical Assessment of Polyvinylpyrrolidone (PVP): As Excipient from Conventional to Controlled Delivery Systems with a Spotlight on COVID-19 Inhibition |
Mallesh Kurakula, G.S.N. Koteswara Rao |
